Skip to content
LexBuild

Preparation for Global Harmonization Task Force Conference in Barcelona, Spain, Including a Discussion of Guidance Proposed for Comment and Currently Under Development and Possibilities for New Topics; Public Meeting; Cancellation

---
identifier: "/us/fr/01-24527"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Preparation for Global Harmonization Task Force Conference in Barcelona, Spain, Including a Discussion of Guidance Proposed for Comment and Currently Under Development and Possibilities for New Topics; Public Meeting; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "01-24527"
section_name: "Preparation for Global Harmonization Task Force Conference in Barcelona, Spain, Including a Discussion of Guidance Proposed for Comment and Currently Under Development and Possibilities for New Topics; Public Meeting; Cancellation"
positive_law: false
currency: "2001-10-01"
last_updated: "2001-10-01"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-24527"
document_type: "notice"
publication_date: "2001-10-01"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "66 FR 49964"
fr_volume: 66
docket_ids:
  - "Docket No. 01N-0384"
fr_action: "Notice."
---

#  Preparation for Global Harmonization Task Force Conference in Barcelona, Spain, Including a Discussion of Guidance Proposed for Comment and Currently Under Development and Possibilities for New Topics; Public Meeting; Cancellation

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is canceling the public meeting for the Global Harmonization Task Force Conference in Barcelona, Spain scheduled for October 1, 2001. The meeting was announced in the *Federal Register* of September 13, 2001 (66 FR 47676). It will be rescheduled at a later date.

**FOR FURTHER INFORMATION CONTACT:**

Kimberly Topper, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7001.

Dated:  September 25, 2001.

Margaret M. Dotzel,

Associate Commissioner for Policy.